Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.
Rim
Christina L
CL
Gitlin
Michael J
MJ
D000328:Adult; D003865:Major Depressive Disorder / Q000188:drug therapy; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D020230:Serotonin Syndrome / Q000139:chemically induced*; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use; D014191:Tranylcypromine / Q000009:adverse effects* / Q000627:therapeutic use
D008996:Monoamine Oxidase Inhibitors; D010879:Piperazines; D012702:Serotonin Antagonists; D013844:Thiazoles; D014191:Tranylcypromine; C092292:ziprasidone